Mineralys CMO Activity and Company Developments Offer Mixed Signals
The Chief Medical Officer of Mineralys Therapeutics, Inc., Dr. David Malcom Rodman, recently executed a series of transactions involving the company's common stock. These sales generated substantial proceeds, while simultaneous option exercises resulted in new holdings. Despite these insider movements, which were conducted under a pre-arranged trad…